ABSTRACT
The prevalence of skin aging and the request for effective treatments have driven dermatological research towards natural solutions. This study investigates the anti-aging efficacy of two bioactive natural polyphenols, Oleocanthal and Oleacein, in a skincare formulation. A single-blind, randomized clinical trial involved 70 participants, using a comprehensive exclusion criterion to ensure participant safety and study integrity. Participants applied the Oleocanthal and Oleacein 1% serum formulation twice daily for 30 days. The efficacy was objectively assessed using the VISIA® Skin Analysis System at baseline, after 15 days, and after 30 days. Results indicated significant wrinkle reduction in most groups. For women aged 45-79 years, the mean change was -33.91% (95% CI: -46.75% to -21.07%). For men aged 20-44 years, it was -51.93% (95% CI: -76.54% to -27.33%), and for men aged 45-79 years, it was -46.56% (95% CI: -58.32% to -34.81%). For women aged 20-44 years, the change was -25.68% (95% CI: -63.91% to 12.54%), not statistically significant. These findings highlight the potential of EVOO-derived polyphenols in anti-aging skincare, particularly for older adults. This research paves the way for further exploration into natural compounds in dermatology, particularly for aging skin management.
Subject(s)
Aldehydes , Cyclopentane Monoterpenes , Phenols , Skin Aging , Humans , Middle Aged , Female , Male , Aged , Adult , Skin Aging/drug effects , Single-Blind Method , Phenols/therapeutic use , Phenols/pharmacologySubject(s)
COVID-19 , Erythema Nodosum , ChAdOx1 nCoV-19 , Erythema Nodosum/chemically induced , Humans , SARS-CoV-2Subject(s)
Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/epidemiology , Adult , Humans , Phenotype , Prevalence , Public Health SurveillanceABSTRACT
No disponible
